Biomedal Diagnostics is developing immunoassays for biomarkers involved in immunological diseases.
As an example of proprietary technology, the anti-hGSTT1 ELISA kit allows to titrate anti-GSTT1 antibodies in human sera, that could appear after organ transplantation.
Diseases such as Hepatitis de novo autoimmune (DNH) could be diagnosed by detection of human anti-hGSTT1 in sera.
Treatment with immunosupressors alleviates the pathogenic process. This product may be used to monitor human organ rejection.